Type 1 Diabetes
Type 1 diabetes is a chronic condition where the pancreas produces little or no insulin, leading to high blood sugar levels. It often develops in children and young adults, requiring lifelong management.
Type 1 Diabetes: Frexalimab Treatment Study
We are studying a new medication, frexalimab, to see if it helps preserve insulin production in young people with newly diagnosed type 1 diabetes. Participants will receive either the medication or a placebo while continuing their insulin therapy.
1-2 years11-15 visitsEfficacy phase (II)Post-Trial Drug AccessInvestigational MedicinesInjectionEndocrinologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have Type 1 Diabetes (T1D)?
- Are you currently taking insulin for your diabetes?
- Have you had any serious infections in the last 30 days?
- Have you received any vaccinations in the last 3 months?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Frexalimab
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Graz
Klinik für Kinder- und Jugendheilkunde Department für Allgemeine Pädiatrie
Graz, Austria
Medizinische Universitaet Innsbruck
Universitätsklinik für Pädiatrie 1
Innsbruck, Austria
Johannes Kepler University Linz
Med Campus III - Universitätsklinik für Kinder- und Jugendheilkunde
Linz, Austria
Sponsor: Sanofi-Aventis Research & Development
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.